JP2015521628A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015521628A5 JP2015521628A5 JP2015518633A JP2015518633A JP2015521628A5 JP 2015521628 A5 JP2015521628 A5 JP 2015521628A5 JP 2015518633 A JP2015518633 A JP 2015518633A JP 2015518633 A JP2015518633 A JP 2015518633A JP 2015521628 A5 JP2015521628 A5 JP 2015521628A5
- Authority
- JP
- Japan
- Prior art keywords
- vlp
- solution
- norovirus
- subpopulation
- chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 68
- 241001263478 Norovirus Species 0.000 claims 37
- 239000000706 filtrate Substances 0.000 claims 21
- 241000700605 Viruses Species 0.000 claims 16
- 239000000463 material Substances 0.000 claims 16
- 239000006166 lysate Substances 0.000 claims 14
- 239000006228 supernatant Substances 0.000 claims 14
- 108090000623 proteins and genes Proteins 0.000 claims 12
- 238000004587 chromatography analysis Methods 0.000 claims 8
- 239000002245 particle Substances 0.000 claims 8
- 239000013592 cell lysate Substances 0.000 claims 7
- 239000012228 culture supernatant Substances 0.000 claims 7
- 210000004027 cell Anatomy 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 238000001542 size-exclusion chromatography Methods 0.000 claims 5
- 239000002904 solvent Substances 0.000 claims 5
- 238000001042 affinity chromatography Methods 0.000 claims 4
- 239000003599 detergent Substances 0.000 claims 4
- 238000012434 mixed-mode chromatography Methods 0.000 claims 4
- 238000000746 purification Methods 0.000 claims 4
- 241000238631 Hexapoda Species 0.000 claims 3
- 241000369757 Sapovirus Species 0.000 claims 3
- 230000001580 bacterial effect Effects 0.000 claims 3
- 238000011118 depth filtration Methods 0.000 claims 3
- 238000001914 filtration Methods 0.000 claims 3
- 238000004191 hydrophobic interaction chromatography Methods 0.000 claims 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 3
- 238000004255 ion exchange chromatography Methods 0.000 claims 3
- 210000004962 mammalian cell Anatomy 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims 3
- 229960005486 vaccine Drugs 0.000 claims 3
- 210000005253 yeast cell Anatomy 0.000 claims 3
- 238000010960 commercial process Methods 0.000 claims 2
- 230000000415 inactivating effect Effects 0.000 claims 2
- 238000011084 recovery Methods 0.000 claims 2
- 238000002965 ELISA Methods 0.000 claims 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims 1
- 239000005909 Kieselgur Substances 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 229920004890 Triton X-100 Polymers 0.000 claims 1
- 239000013504 Triton X-100 Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 238000005571 anion exchange chromatography Methods 0.000 claims 1
- 238000005277 cation exchange chromatography Methods 0.000 claims 1
- 238000005352 clarification Methods 0.000 claims 1
- 239000012459 cleaning agent Substances 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 238000012872 hydroxylapatite chromatography Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000011140 membrane chromatography Methods 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 claims 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261663218P | 2012-06-22 | 2012-06-22 | |
| US61/663,218 | 2012-06-22 | ||
| US201361794086P | 2013-03-15 | 2013-03-15 | |
| US61/794,086 | 2013-03-15 | ||
| PCT/US2013/047249 WO2013192604A1 (en) | 2012-06-22 | 2013-06-24 | Purification of virus like particles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015521628A JP2015521628A (ja) | 2015-07-30 |
| JP2015521628A5 true JP2015521628A5 (cg-RX-API-DMAC7.html) | 2016-08-12 |
| JP6553509B2 JP6553509B2 (ja) | 2019-07-31 |
Family
ID=49769461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015518633A Active JP6553509B2 (ja) | 2012-06-22 | 2013-06-24 | ウイルス様粒子の精製 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10167320B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2864478B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6553509B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102110876B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN114085273B (cg-RX-API-DMAC7.html) |
| AR (1) | AR091538A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013277959B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2879815A1 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2015DN00089A (cg-RX-API-DMAC7.html) |
| JO (1) | JOP20130186B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX366234B (cg-RX-API-DMAC7.html) |
| SG (2) | SG11201408459VA (cg-RX-API-DMAC7.html) |
| TW (1) | TWI647310B (cg-RX-API-DMAC7.html) |
| UY (1) | UY34875A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013192604A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008302276B2 (en) | 2006-09-29 | 2013-10-10 | Takeda Vaccines, Inc. | Method of conferring a protective immune response to norovirus |
| EP2601970B1 (en) | 2006-09-29 | 2016-10-26 | Takeda Vaccines, Inc. | Norovirus vaccine formulations |
| KR101576219B1 (ko) | 2007-03-14 | 2015-12-10 | 다케다 백신즈 인코포레이티드 | 바이러스 유사 입자 정제 |
| BR112014000656A2 (pt) | 2011-07-11 | 2017-02-14 | Takeda Vaccines Inc | formulações de vacina parenteral contra norovírus |
| JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| JP5861001B2 (ja) * | 2013-07-11 | 2016-02-16 | タカラバイオ株式会社 | 非エンベロープウイルスの製造方法 |
| EP3052631B1 (en) | 2013-10-03 | 2019-08-07 | Takeda Vaccines, Inc. | Methods of detection and removal of rhabdoviruses from cell lines |
| CN103981084B (zh) * | 2014-05-29 | 2015-11-18 | 黑龙江省科学院微生物研究所 | 水中病毒分离提取装置及水中札幌病毒的提取方法 |
| WO2016111343A1 (ja) * | 2015-01-09 | 2016-07-14 | タカラバイオ株式会社 | 非エンベロープウイルス粒子の製造方法 |
| US10920288B2 (en) | 2015-01-16 | 2021-02-16 | Takeda Vaccines, Inc. | Detection of particle-contained reverse transcriptase activity |
| CN105907729B (zh) * | 2015-05-05 | 2019-08-16 | 广东东阳光药业有限公司 | 一种制备人乳头瘤病毒l1蛋白类病毒样颗粒的方法 |
| CN107034198B (zh) * | 2015-07-15 | 2021-03-09 | 长春百克生物科技股份公司 | 一种嵌合诺如病毒p颗粒及其制备和应用 |
| EP3341019A4 (en) * | 2015-08-28 | 2019-07-31 | Ology Bioservices, Inc. | NOROVIRUS VACCINE |
| CN105779399A (zh) * | 2016-03-28 | 2016-07-20 | 广西壮族自治区林业科学研究院 | 一种昆虫杆状病毒纯化方法 |
| GB201614050D0 (en) | 2016-08-17 | 2016-09-28 | Glaxosmithkline Ip Dev Ltd | Method for purifying viral vectors |
| US20190194628A1 (en) * | 2016-09-01 | 2019-06-27 | Takeda Vaccines, Inc. | Methods for producing virus for vaccine production |
| EP4382183A3 (en) | 2017-03-06 | 2024-08-21 | Guangzhou Realbenefitspot Pharmaceutical Co., Ltd. | Methods of producing and characterizing virus vaccine and virus vaccine composition |
| EP3420076B1 (en) | 2017-03-06 | 2024-02-21 | Guangzhou Realbenefitspot Pharmaceutical Co., Ltd. | Methods of producing and characterizing virus vaccine and virus vaccine composition |
| WO2019158653A1 (en) | 2018-02-15 | 2019-08-22 | Icon Genetics Gmbh | Immunogenic composition and vaccine for generating an immune response to norovirus |
| CN108676781A (zh) * | 2018-05-18 | 2018-10-19 | 山东信得动物疫苗有限公司 | 一种重组禽流感病毒的工业化纯化方法 |
| CN111848749A (zh) * | 2018-05-23 | 2020-10-30 | 中国农业科学院兰州兽医研究所 | 猪细小病毒VLPs抗体检测试剂盒及其制备方法、应用 |
| MX2021011059A (es) | 2019-03-12 | 2021-10-13 | Icon Genetics Gmbh | Particulas tipo norovirus con estabilidad mejorada. |
| US12403164B2 (en) | 2019-09-30 | 2025-09-02 | Bioverativ Therapeutics Inc. | Lentiviral vector formulations |
| EP4340874A1 (en) | 2021-05-21 | 2024-03-27 | Takeda Vaccines, Inc. | Solid composition, freeze-drying method and glass vial |
| CN118742557A (zh) * | 2021-06-28 | 2024-10-01 | 威斯特有限责任公司,以梅德基因实验室名义营业 | 札幌病毒疫苗 |
| CN116789773B (zh) * | 2022-11-30 | 2024-02-20 | 华北制药金坦生物技术股份有限公司 | 一种胞内表达病毒样颗粒的粗纯方法 |
| WO2025077800A1 (en) * | 2023-10-12 | 2025-04-17 | Chengdu Kanghua Biological Products Co., Ltd. | Purification of norovirus virus-like particles (vlps) |
| CN118126202B (zh) * | 2024-05-07 | 2024-07-30 | 上海瑞宙生物科技有限公司 | 一种诺如病毒类病毒颗粒及其应用 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2833106B2 (ja) | 1990-02-21 | 1998-12-09 | 株式会社島津製作所 | 液体クロマトグラフ |
| WO1994026087A2 (en) | 1993-05-14 | 1994-11-24 | Connor Kim C O | Recombinant protein production and insect cell culture and process |
| CA2189882C (en) | 1994-05-16 | 2005-09-20 | Kathrin U. Jansen | Papillomavirus vaccines |
| AR004464A1 (es) | 1994-11-14 | 1998-12-16 | Merck Sharp & Dohme | Un metodo para producir una proteina de capside de papilomavirus |
| JP3316325B2 (ja) | 1994-12-20 | 2002-08-19 | 富士シリシア化学株式会社 | ビール安定化処理用シリカゲル及びその製造方法並びにビールの安定化処理方法 |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| AU738585B2 (en) | 1996-11-08 | 2001-09-20 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Synthesis and purification of hepatitis C virus-like particles |
| DK1015561T3 (da) | 1997-09-05 | 2006-11-13 | Medimmune Inc | In vitro-fremgangsmåde til adskillelse/gensamling af papillomavirus-lignende partikler (VLP'er) |
| DE19823814A1 (de) | 1998-05-27 | 1999-12-02 | Octapharma Ag Ziegelbruecke | Verfahren zur Trennung und/oder Isolierung von Plasmaproteinen mit annularer Chromatographie |
| EA200100236A1 (ru) | 1998-08-14 | 2001-08-27 | Мерк Энд Ко., Инк. | Способ очистки вирусных частиц, подобных вирусу папилломы человека |
| ES2313881T3 (es) * | 1999-02-05 | 2009-03-16 | MERCK & CO., INC. | Formulaciones de vacunas frente al papilomavirus humano. |
| US6349843B1 (en) | 1999-04-01 | 2002-02-26 | The Vollrath Company Llc | Pan removal ramp |
| US7067638B1 (en) | 1999-06-22 | 2006-06-27 | Japan As Represented By Director-General National Institute Of Infectious Diseases | Small round structured virus (SRSV) detection kit |
| DE10012732A1 (de) | 2000-03-18 | 2001-09-20 | Aventis Behring Gmbh | Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung |
| JP2003066021A (ja) | 2001-08-28 | 2003-03-05 | Hiroshi Shionoya | 連続分取液体クロマトグラフィー装置とそれを用いる方法 |
| AU2003213060A1 (en) | 2002-02-14 | 2003-09-04 | Novavax, Inc. | Optimization of gene sequences of chimeric virus-like particles for expression in insect cells |
| WO2003102132A2 (en) | 2002-04-26 | 2003-12-11 | Genetech, Inc. | Non-affinity purification of proteins |
| AU2003268210A1 (en) | 2002-08-28 | 2004-03-19 | Introgen Therapeutics Inc. | Chromatographic methods for adenovirus purification |
| US7879338B2 (en) | 2003-07-21 | 2011-02-01 | Boyce Thompson Institute For Plant Research | Vectors and methods for immunization against norovirus using transgenic plants |
| US7481997B1 (en) | 2004-02-12 | 2009-01-27 | Montana State University | Snow mountain virus genome sequence, virus-like particles and methods of use |
| US8277819B2 (en) | 2005-06-16 | 2012-10-02 | Children's Hospital Medical Center | Norovirus particle for use as an antiviral or vaccine |
| EP1736538A1 (en) | 2005-06-21 | 2006-12-27 | Cytos Biotechnology AG | Process for the preparative purification of virus-like-particles (VLPs) |
| JP5215865B2 (ja) | 2005-11-22 | 2013-06-19 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド | ノロウイルス抗原およびサポウイルス抗原 |
| BRPI0620859A2 (pt) | 2005-12-29 | 2011-11-22 | Boehringer Ingelheim Vetmedica, Inc. | vacina de combinação multivalente contra pcv2 |
| US9439959B2 (en) | 2006-07-27 | 2016-09-13 | Takeda Vaccines, Inc. | Chimeric influenza virus-like particles |
| EP2601970B1 (en) | 2006-09-29 | 2016-10-26 | Takeda Vaccines, Inc. | Norovirus vaccine formulations |
| AU2008302276B2 (en) * | 2006-09-29 | 2013-10-10 | Takeda Vaccines, Inc. | Method of conferring a protective immune response to norovirus |
| US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| KR101576219B1 (ko) | 2007-03-14 | 2015-12-10 | 다케다 백신즈 인코포레이티드 | 바이러스 유사 입자 정제 |
| EP2027875A1 (en) * | 2007-08-23 | 2009-02-25 | Octapharma AG | A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC) |
| EP2235165A1 (en) | 2007-12-21 | 2010-10-06 | Cytos Biotechnology AG | Process for clarifying cell homogenates |
| SG2013057732A (en) | 2008-08-08 | 2015-02-27 | Ligocyte Pharmaceuticals Inc | Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| WO2010062757A1 (en) | 2008-11-03 | 2010-06-03 | Ligocyte Pharmaceuticals, Inc. | Improved methods for isolating enveloped virus-based vlps free of infectious agents |
| US8945895B2 (en) * | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
| AU2011207355B2 (en) | 2010-01-21 | 2015-04-02 | Takeda Vaccines, Inc. | Targeted heterologous antigen presentation on Calicivirus virus-like particles |
| JP5903101B2 (ja) | 2010-09-20 | 2016-04-13 | バイオ−ラッド ラボラトリーズ インコーポレーティッド | クロマトグラフィーにおける生成物と複合体形成した夾雑物の分離方法 |
| FI122520B (fi) | 2010-10-15 | 2012-03-15 | Vesna Blazevic | Noroviruksen kapsidi ja rotaviruksen VP6-proteiini käytettäväksi yhdistelmärokotteena |
| CN102260651A (zh) | 2011-06-24 | 2011-11-30 | 华中科技大学同济医学院附属协和医院 | 一种纯化病毒样颗粒蛋白的方法及其应用 |
| JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| JP2015015931A (ja) | 2013-07-12 | 2015-01-29 | 株式会社Ｕｍｎファーマ | ウイルス様粒子を含む培養物の製造方法 |
-
2013
- 2013-06-19 JO JOP/2013/0186A patent/JOP20130186B1/ar active
- 2013-06-21 TW TW102122276A patent/TWI647310B/zh active
- 2013-06-24 SG SG11201408459VA patent/SG11201408459VA/en unknown
- 2013-06-24 CA CA2879815A patent/CA2879815A1/en active Pending
- 2013-06-24 JP JP2015518633A patent/JP6553509B2/ja active Active
- 2013-06-24 CN CN202111173161.7A patent/CN114085273B/zh active Active
- 2013-06-24 SG SG10201610753YA patent/SG10201610753YA/en unknown
- 2013-06-24 AU AU2013277959A patent/AU2013277959B2/en active Active
- 2013-06-24 CN CN201380043618.XA patent/CN104583393A/zh active Pending
- 2013-06-24 WO PCT/US2013/047249 patent/WO2013192604A1/en not_active Ceased
- 2013-06-24 EP EP13807804.3A patent/EP2864478B1/en active Active
- 2013-06-24 US US13/925,449 patent/US10167320B2/en active Active
- 2013-06-24 MX MX2014015842A patent/MX366234B/es active IP Right Grant
- 2013-06-24 KR KR1020157001131A patent/KR102110876B1/ko active Active
- 2013-06-24 UY UY0001034875A patent/UY34875A/es active IP Right Grant
- 2013-06-24 AR ARP130102218 patent/AR091538A1/es active IP Right Grant
-
2015
- 2015-01-06 IN IN89DEN2015 patent/IN2015DN00089A/en unknown
-
2018
- 2018-11-27 US US16/201,073 patent/US11091519B2/en active Active
-
2021
- 2021-08-11 US US17/399,731 patent/US12286456B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015521628A5 (cg-RX-API-DMAC7.html) | ||
| DK2134360T3 (en) | Purification of virus-like particle | |
| US11629339B2 (en) | Aseptic purification process for viruses | |
| CA2584142A1 (en) | Improved viral purification methods | |
| HK1248763A1 (en) | Aseptic purification process for viruses | |
| CN106574252B (zh) | 从细胞培养物中纯化脊髓灰质炎病毒的方法 | |
| JP2022512377A (ja) | アフィニティークロマトグラフィーを用いたワクチン用ウイルスの精製方法 | |
| WO2020153390A1 (ja) | 活性炭材料を使用する工程を含む抗体精製方法 | |
| AU2013242822B2 (en) | Virus like particle purification | |
| CN117660373A (zh) | 一种慢病毒大规模纯化方法及其应用 | |
| CN120796207A (zh) | 一种快速高效的慢病毒纯化方法 | |
| KR20060132590A (ko) | 재조합 단백질을 제조하고 정제하는 방법 | |
| WO2021255835A1 (ja) | アパタイトカラムを使用したウイルスの精製方法 | |
| AU2016269506A1 (en) | Virus like particle purification | |
| HK1138795B (en) | Virus like particle purification |